Capital Labs fuels new chapter in Australian innovation with $828,476 raise for medicinal cannabis start-up

EQUITY crowd-sourced funding platform Capital Labs is powering a new era in Australian healthcare innovation with a successful raise of more than $800,000 for medicinal cannabis start-up Greenfield MC Global. 

Greenfield MC Global raised a total of $828,476 from 547 investors by partnering with Capital Labs, surpassing its minimum target of $500,000 days before the raise closed on Thursday December 12.

“At Capital Labs, we partner with strong companies creating innovations with impact, who are ready to scale-up,” said Joseph Barry of Capital Labs.

“We know the challenge for many innovators is accessing the expertise that’s needed to future-proof their company with a realistic valuation and capital raise, marketing strategy and solid brand recognition. This is where we are more than a platform; we’re a full-service capital raising partner,” Mr Barry said.

Part of The iQ Group Global investment enterprise, companies which partner with Capital Labs gain access to investment banking experts who structure the raise for future exit opportunities, such as a public offering, and marketing expertise to generate publicity and reach untapped like-minded audiences.

“When we partnered with Greenfield MC Global, they accessed our in-house experts as part of their full-service capital raise, including a bespoke marketing and media campaign, video production service and audience development strategy," Mr Barry said.

“The targeted campaign didn’t just result in a successful raise beyond their minimum $500,000 target, it generated publicity and investor spread that has set them up for a future listing, slated in their offer document for 2021, so that Greenfield MC Global can drive a new future in patient care for Australia,” Mr Barry said.

One of the first ASIC authorised equity crowd-sourced funding (CSF) platforms in Australia, Capital Labs only partners with companies launching technology and innovations that have a positive impact on Australia’s future. For investors, Capital Labs provides access to early-stage retail investment opportunities in innovative companies and technologies in a variety of sectors for as little as $100.

“Capital Labs has a unique competitive advantage by leveraging the group’s in-house expertise in asset management and investment banking. This intellectual property is not typically afforded to start-ups but is critical for creating value for investors and ultimately for delivering life-changing innovations to the world,” The iQ Group Global chairman and CEO, George Syrmalis said.

After their successful raise with Capital Labs, Greenfield MC Global is ready to hit the ground running next year.

“Capital Labs’ robust full-service offering enabled us to achieve nationwide outreach to a crowd of passionate investors who we otherwise could not have reached and who could not have otherwise accessed the investment offering,” Greenfield MC Global chairman and president, Arjun Chhabra said.

“With this raise and our new community of investors, we are thrilled to be a force in redefining the healthcare landscape in Australia from 2020.”

ends